Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > April 2004

« Previous month Next month »

30-Apr-2004

1Q results lend weight to signs of Euro chemicals recovery

30-Apr-2004 - BASF and Merck KGaA have joined DSM in reporting encouraging first-quarter 2004 results, raising hopes further that the European chemicals sector may be about to move into recovery mode, writes...

29-Apr-2004

Oligo suppliers should look to their laurels

29-Apr-2004 - Manufacturers of custom synthetic oligonucleotides (oligos) could see competition from new entrants into the sector, according to a survey which finds that customers are not entirely happy with their suppliers.

Recordati sells Sophartex, expands Polfa Kutno stake

29-Apr-2004 - Italy's Recordati has sold off Sophartex, a French subsidiary specialising in the contract manufacture of finished pharmaceutical dosage forms, continuing its strategy of divesting businesses outside its core focus of...

Catalysts from UK start-up promise cleaner, greener reactions

29-Apr-2004 - A new company spun out from the University of Durham in the UK, called LyraChem, has developed a new catalytic technology for the pharmaceutical and chemical sectors that should reduce...

Comark products to get cross-contamination protection

29-Apr-2004 - A UK-based specialist in antimicrobial coating technology, BioCote, has entered into an agreement with Comark to develop more hygienic handheld thermometers and data loggers. The new products are intended for...

28-Apr-2004

DSM outperforms expectations in 1Q

28-Apr-2004 - DSM has said it expects 'clearly higher' net profit from ordinary operations in 2004, after reporting an unexpected increase in first-quarter operating earnings.

French study evaluates consequences of REACH legislation

28-Apr-2004 - The impact on the French chemicals industry of implementing the European Union's REACH (Registration, Evaluation and Authorisation of Chemicals) proposals could be as high €800 million in testing alone and...

US approval for Profile's nebuliser

28-Apr-2004 - Profile Therapeutics of the UK has been granted approval from the US Food and Drug Administration (FDA) for Prodose, its nebuliser system that can improve the delivery of inhaled drugs.

DMV ramps up excipient capacity with new plant

28-Apr-2004 - DMV International, the industrial ingredients division of the Netherlands' Campina, is planning to open a dedicated facility in Germany for the production of excipients for direct compression.

New granulator from L B Bohle

28-Apr-2004 - Germany's L B Bohle, a specialist in dispensing, granulating and milling equipment, has introduced a new granulator for pharmaceutical applications that allows for continuous throughput of materials.

Management buy-out at Lurgi Life Science

28-Apr-2004 - Lurgi, part of the mg technology group, has sold off a pharmaceutical and chemical engineering unit to two former executives in a management buyout.

Osteoporosis sees new wave of treatment options

28-Apr-2004 - Osteoporosis sufferers are set to benefit from an influx of new drug treatments which are expected to dominate the market and give patients an unprecedented choice of treatment options, according...

27-Apr-2004

Lonza teams up with RNA-TEC for oligo production

27-Apr-2004 - Switzerland's Lonza, one of the leading contract manufacturers of active pharmaceutical ingredients, has forged a collaboration with RNA-TEC of Belgium to provide broad-ranging contract production of oligonucleotides, a new class...

Captisol hikes budesonide delivery to lungs

27-Apr-2004 - A formulation of the steroid drug budesonide, made using a solubility technology developed by US company CyDex, has outperformed one of the leading drugs for asthma on the market in...

EC mulls progress in European biotech

27-Apr-2004 - The European Commission has reported on its progress in building up Europe's competitiveness in the biotechnology and concludes that while positive steps have been taken, there is still much to...

Seconds out in fast-melt lawsuit

27-Apr-2004 - St Louis, USA-based KV Pharmaceutical says that the US District Court for the District of Minnesota has denied a motion for a preliminary injunction by two rival drug delivery companies...

Strakan starts trials of drug conjugate

27-Apr-2004 - Scottish pharmaceutical company Strakan has started a Phase I trial of a testosterone product that should overcome the limitations of delivering the drug by mouth.

26-Apr-2004

Sanofi-Aventis looks likely as Novartis ducks out

26-Apr-2004 - Switzerland's Novartis has decided to withdraw from any negotiations with Aventis over a possible merger, after official discussions with the latter and fellow French-based company Sanofi-Synthelabo got underway.

Rhodia makes €400m from divestments

26-Apr-2004 - French chemicals company Rhodia has announced three new deals which keep it on track to divest €700 million-worth of businesses by the end of the year as it aims for...

Research reveals scale of child-proof packaging problems

26-Apr-2004 - Designers of child-proof packaging must always work against the paradox that a package which is hard for a child to open can often also be difficult for the adult patient...

Safety syringe goes into production

26-Apr-2004 - US company Globe Medical Tech has started production of a new type of safety syringe developed by Maxxon that should cost no more than a regular, non-safe disposable syringe.

Swedish intelligent packaging trials underway

26-Apr-2004 - Swedish company Cypak has started two trials of its Intelligent Pharmaceutical Packaging (IPP) technology, which offers an alternative to radiofrequency identification (RFID) for tracking the use of medicines.

22-Apr-2004

Ulster says yes to nanotechnology

22-Apr-2004 - The University of Ulster yesterday opened a new Nanotechnology Research Institute at its Jordanstown campus in Northern Ireland, and says it is the only institute of its type in the...

Stedim enlists US partner to offer streamlined biomanufacturing

22-Apr-2004 - Developer of disposable container systems Stedim has teamed up with a Californian firm to bring to market an alternative to conventional media kitchens, designed to reduce the costs of biomanufacturing.

New player on biomanufacturing scene

22-Apr-2004 - The US-based Cook Group is to enter the biomanufacturing sector, revealing an initial $45 million investment in a state-of-the-art facility.

Strong sales for Millipore, good sign for biopharma

22-Apr-2004 - Filtration specialist Millipore has reported impressive growth in sales in the first quarter of 2004, suggesting that the strength of the biopharmaceutical industry - Millipore's primary customer - may be...

Novartis introduces film strips for flu range

22-Apr-2004 - Novartis Consumer Health has launched two of its OTC flu remedies in portable dissolvable strips, thought to be the first such products to use the novel delivery format.

21-Apr-2004

Elan finds new partner for NanoCrystal tech

21-Apr-2004 - Ireland's Elan Corp has signed up another heavyweight partner - Switzerland's Roche - for its NanoCrystals technology, designed to improve the solubility of drug compounds.

Akzo tops expectations in 1Q but sees tough times ahead

21-Apr-2004 - The Netherlands-based pharmaceuticals, coatings and chemicals firm Akzo Nobel has posted a 7 per cent rise in net income to €176 million for the first quarter of 2004, a little...

BMS signs up for Dowpharma solubility service

21-Apr-2004 - Dowpharma has agreed to apply a proprietary solubilisation service to drug compounds from Bristol-Myers Squibb in a deal which promises to improve the bioavailability and activity of BMS' pipeline compounds....

Standards company looks to CEE

21-Apr-2004 - UK-based analysis specialist LGC has signed two agreements with Poland's Institute of Industrial Organic Chemistry (IPO), highlighting the company's strategy of establishing partnerships to develop outside its home market.

New approach offers drug-discovery shortcut

21-Apr-2004 - A new screening approach which can identify a new drug mechanism of action without the need for an appropriate molecular target has been used to suppress genetic mutation. The discovery...

Electron lab notebook software gets revamp

21-Apr-2004 - IntelliChem, a developer of electronic laboratory notebooks (ELN) for the drug discovery and development industry, has launched a new ELN platform that can be used right across any pharmaceutical or...

20-Apr-2004

Signs of progress in gene therapies

20-Apr-2004 - Growing knowledge about how to manage the risks of gene therapy could improve the chances of developing successful treatments, said experts meeting last week to weigh up the progress made...

Accession countries lament EU science lag

20-Apr-2004 - Scientific bodies in the accession companies to the European Union have expressed concern about the overall standard of science across the EU at a meeting in Slovenia.

Healthy growth expected for nanocatalysts

20-Apr-2004 - The global market for nanocatalysts will amount to $3.7 billion in 2004 and is expected to reach $5.0 billion in 2009, according to soon-to-be-released market research.

Sale agreed for Dynamit Nobel

20-Apr-2004 - Germany's MG technologies has agreed to sell the bulk of its Dynamit Nobel chemicals division, sealing the fate of a company that has been on the block since last November,...

More consolidation in Israeli generics/API sector?

20-Apr-2004 - Israeli press reports say US generics company IVAX is close to finalising a merger with local firm Agis, which manufactures generics and active pharmaceutical ingredients (APIs).

Kurve tech ahead by a nose

20-Apr-2004 - US company Kurve Technology has developed a nasal spray device that should make delivery of drugs in this way cheaper and more efficient.

19-Apr-2004

Label tech avoids product contamination

19-Apr-2004 - Northwest Coatings has been granted a US patent on a new form of radiation-cured laminated label for plastic pharmaceutical or food containers that prevents the leaching of components into the...

MonoSol buys UK edible films company

19-Apr-2004 - US water-soluble films company MonoSol has bought the UK division of Aquafilm, giving it access to substantial manufacturing capabilities in Europe and its range of edible films, report Phil Taylor...

Peakdale upgrades kilo lab

19-Apr-2004 - UK contract research company, Peakdale Molecular has invested in two large-scale glass reaction systems from Radleys to upgrade the capabilities of its kilo-scale laboratory.

Merck completes scientific supply unit sale

19-Apr-2004 - Germany's Merck KGaA has completed the $1.65 billion (€1.32bn) sale of its laboratory distribution business, VWR International, to US investment firm Clayton, Dubilier & Rice.

Google search for research could help industry

19-Apr-2004 - The Internet search engine Google has launched a pilot project with 17 universities around the world, including institutes in Italy and the UK, aimed at improving access to research papers.

15-Apr-2004

Packaging software meets FDA regulations

15-Apr-2004 - 3M has launched an updated version of its Integrated Packaging Tool software that brings it into compliance with the US Food and Drug Administration's 21 CFR Part 11 regulations on...

Scientists achieve tighter control of batch reactions

15-Apr-2004 - Two Dutch researchers have developed a method for managing batch productions - widely used in the pharmaceutical industry - which has the potential of improving yields and reducing the number...

Sigma-Aldrich buys Ultrafine

15-Apr-2004 - UK fine chemical company Ultrafine is to be acquired by Sigma-Aldrich of the US in a move aimed at strengthening the latter's offerings for the pharmaceutical and biotech industry.

European API supply chain affected by generics expansion

15-Apr-2004 - The global generics industry is growing at such a rate that it can now support billion dollar companies, with activities crossing into active pharmaceutical ingredient (API) production and R&D. This...

MET stirred cell gets tougher skin

15-Apr-2004 - Membrane Extraction Technology has launched a new version of its METcell - a chemically-resistant high pressure stirred cell used in development laboratories in the pharmaceutical and chemical industry - that...

14-Apr-2004

New player in Indian API supply

14-Apr-2004 - India's Dishman Pharmaceuticals and Chemicals has set up a company specialising in the contract manufacture of active pharmaceutical ingredients (APIs) and intermediates that is specifically aimed at winning business from...

US generics firm eyes Eastern Europe

14-Apr-2004 - Top 10-ranked generics company IVAX has bid to acquire Polish pharmaceutical company Polfa Kutno, already the subject of an offer by Italy's Recordati. Israel's Teva is also rumoured to be...

UK says it is still a nanotech player

14-Apr-2004 - The UK's Science and Innovation Minister, Lord Sainsbury, has defended his government's record on nanotechnology, after last week's report from the House of Commons science and technology select committee blamed...

Sanofi gearing up for Aventis bid

14-Apr-2004 - France's Sanofi-Synthelabo has announced plans to sell two of its products to GlaxoSmithKline in a deal which forms part of its strategy to take over Aventis.

Hovione expands solid dosage form range

14-Apr-2004 - Portugal's Hovione has expanded the range of pharmaceutical fine chemical products it can supply to customers after installing a new spray drying facility to exploit the latest technology in particle...

13-Apr-2004

GE completes Amersham acquisition

13-Apr-2004 - General Electric has completed its €8.1 billion acquisition of UK healthcare company Amersham, promising to create a new company that will 'change the face of healthcare,' according to GE chief...

FDA plans meeting to go over 21 CFR Part 11

13-Apr-2004 - The US Food and Drug Administration is planning to hold a meeting in June to re-examine its regulations on electronic records and signatures, used to generate the audit trail in...

Transgenics - on the cusp of fulfilling promise?

13-Apr-2004 - Despite years of promises, there is still not a single product on the market that has been manufactured in a genetically-engineered organism. But a soon-to-be released market report maintains that...

Industrial-scale aspirator for spillages

13-Apr-2004 - Ilmvac of Germany has launched a machine for cleaning up spills of of toxic or biological fluids in the lab or process environment.

09-Apr-2004

Gene finding could yield improved smallpox vaccine

09-Apr-2004 - Scientists studying vaccinia virus, a close relative of smallpox, have discovered that a gene necessary for virus replication also plays a key role in turning off inflammation, a crucial antiviral...

Cobra licenses DNA process to AstraZeneca

09-Apr-2004 - Cobra Biomanufacturing has granted AstraZeneca the right to use its proprietary DNA manufacturing process to make nucleic acids for use in its drug discovery operations.

08-Apr-2004

UK losing lead in nanotechnology

08-Apr-2004 - Leaving aside the safety concerns surrounding nanotechnology set out in In-Pharmatechnologist.com's lead article today, a report commissioned by the UK government has claimed that a lack of foresight by both...

New bathless tablet tester reaches UK

08-Apr-2004 - Distek has developed a new product in its range of devices for testing how well pharmaceutical tablets dissolve that does not need a water bath. The benefit? A reduction in...

Tiny tech could be big health problem

08-Apr-2004 - A scientist has claimed that nanotechnology - devoted to engineering tiny machines with applications as diverse as drug delivery, electronics and materials science - could pose a health hazard and...

Rexam strengthens position in plastics for pharma

08-Apr-2004 - UK-based packaging company Rexam has provided further evidence of its commitment to the pharmaceutical sector with the purchase of Plastic Omnium Medical, a company specialising in plastic components for medical...

07-Apr-2004

Daiichi to carve out manufacturing division

07-Apr-2004 - Daiichi Pharmaceutical is to set up a new manufacturing subsidiary in a bid to profit from forthcoming Japanese legislation that makes it easier for firms to produce drugs for third...

Something fishy in fast-melt tablets

07-Apr-2004 - Encapsulation specialist RP Scherer, part of the Cardinal Health group, has been granted a patent on a technology that could be used to reduce the amount of flavours and sweeteners...

'Crystal engineering' to improve drug design

07-Apr-2004 - A new technique for engineering protein crystals is helping scientistsfigure out the three-dimensional structures of some important biological molecules, including a key plague protein whose structure has eluded researchers until...

LifeCycle wins contract for tiny particle tech

07-Apr-2004 - Danish biotechnology company LifeCycle Pharma has won a contract with Italy's Recordati to develop an improved formulation of Zanidip (lercanidipine), used for the treatment of hypertension, reports Phil Taylor.

06-Apr-2004

Novo adds another new plant

06-Apr-2004 - Novo Nordisk has broken ground on a new manufacturing facility in Kalundborg, Denmark, that will produce liraglutide, a potential new product for treating type 2 diabetes.

Ireland backs biotech start-ups

06-Apr-2004 - The first in a series of government-funded incubation facilities opened in Ireland this week, designed to nurture the development of biotech companies.

Blister packer cuts validation work

06-Apr-2004 - IWKA PacSystems of the UK has introduced a new blister packing machine that can dramatically reduce the time it takes to carry out validation and get into production compared to...

Accession countries fear data exclusivity clause

06-Apr-2004 - A number of countries set to join the European Union in May, including Hungary, have signed a petition against new EU legislation that they claim would significantly raise the cost...

UK filter firm expands into US

06-Apr-2004 - UK filtration specialist Domnick Hunter has made a foray into the US market with the purchase of a Californian company specialising in filtration for the biopharmaceutical, food and beverage and...

US biotech boosts production capacity

06-Apr-2004 - US biotechnology company Genentech is planning to build a new large-scale mammalian cell culture manufacturing facility in California which will be the largest of its kind in the world.

Sweeter way to make drug precursor

06-Apr-2004 - Scientists have started to develop what could be a biosynthetic route to producing compounds that serve as precursors to a range of industrial chemicals, including pharmaceuticals.

Scientists give time and skills for developing world

06-Apr-2004 - A non-profit pharmaceutical company has set up a network of volunteer scientists in order to plug a hole in medical research - the development of medicines for diseases that affect...

05-Apr-2004

Liquid capsules: the next big thing?

05-Apr-2004 - Isopak, a company specialising in small-scale pharmaceutical production equipment, will introduce a new machine next month that overcomes one of the major obstacles to making capsules that can deliver liquid...

Rhodia Pharma expands in UK

05-Apr-2004 - Rhodia Pharma Solutions has completed a new extension to its production operation in Dudley, outside Newcastle, in the UK to strengthen its ability to provide custom manufacturing services to pharmaceutical...

UK child resistance legislation needs attention, says CSPG

05-Apr-2004 - The UK's recently adopted standard for child resistance in non-recloseable pharmaceutical packaging such as blister packs contains a serious flaw that must be addressed, according to Stephen Wilkins, secretary of...

Cationic lipids deliver siRNA to tumours

05-Apr-2004 - US company NeoPharm believes it may have overcome one of the major limitations of using RNA interference (RNAi) or gene silencing as a systemic treatment.

Aventis makes eyes at Novartis

05-Apr-2004 - Aventis has formally invited Novartis into merger talks as it fends off an unsolicited takeover bid from Sanofi-Synthelabo.

02-Apr-2004

Virtual model shows cost savings with disposable manufacturing

02-Apr-2004 - Several companies in the biopharmaceutical technology arena are championing the concept of disposable manufacturing as a simple, cost-effective way of making biologic drugs. But data on the actual cost benefits...

Faster, more sensitive leak testing for vials

02-Apr-2004 - Spain's Telstar Industrial is developing a technology for leak testing of pharmaceutical packages that could revolutionise the way this vital quality control function is carried out in the industry.

Metal detection firm cracks stainless steel nut

02-Apr-2004 - Weighing and metal detection specialist Sartorius has developed a new detector that solves a tricky problem - how to detect stainless steel shards in products like blister packs that contain...

Flamel picks up first payment on human insulin

02-Apr-2004 - French drug delivery firm Flamel Technologies has received a $5 million milestone payment from Bristol-Myers Squibb, which acquired rights to Flamel's formulation of long-acting human insulin in August last year.

« Previous month Next month »